Biotech ETFs Muddled Despite Amgen Strength

by Trading & Investing | 02/08/2022, 14:52

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share buybacks. On Tuesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) was down 0.1%, the iShares Biotechnology ETF (IBB) fell 0.1%, and the VanEck Vectors Biotech ETF (BBH) was unchanged. Meanwhile, […] Read more at ETFtrends.com.

Dow Finally Clears 45,000 by Knowledge Resources
Weak Jobs Report Stalls Market Momentum by Knowledge Resources
Volatility Closes Below 15 by Knowledge Resources
Record Highs and Overbought Conditions Remain in Focus by Knowledge Resources
Volatility Spikes On Fed Drama by Knowledge Resources